Biobeat
Biobeat raises $45M Series B at $200M valuation
Quick Facts
Biobeat: Series B Funding Round
Biobeat has successfully raised $45M in Series B funding, reaching a valuation of $200M.
Company Overview
Non-invasive continuous monitoring wearables
Funding Details
The Series B round was led by Awz Ventures, with participation from iAngels.
Company Information
- Headquarters: Petah Tikva, Israel
- Founded: 2016
- Employees: 100+
- Category: HealthTech
Investment
Biobeat plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Awz Ventures: Verified investor in Series B
- iAngels: Verified investor in Series B
Key Investors
About the Author
Related Company Reports
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
